Dr. Max Sonnleitner, CTO

Dr. Max Sonnleitner is CTO of BIOIDENT. Prior to joining BIOIDENT, Dr. Max Sonnleitner served as Vice President R&D Life Science of NANOIDENT AG. Dr. Sonnleitner is a world wide recognized specialist in the fields of fluorescence microscopy and biophotonics and renowned for his profound knowledge of various microscopy techniques and biochip readout technologies. As Vice President R&D of NANOIDENT’s Life Science Division, Dr. Sonnleitner was responsible for the adoption of organic semiconductor technologies to biophotonic applications. Dr. Sonnleitner studied technical physics specializing in biophysics at the Kepler University, in Linz, Austria. After receiving his doctorate at the Institute for Biophysics, Sonnleitner managed the “Ultrasensitive Fluorescence Microscopy/Device Development” division at the newly founded “Center for Biomedical Nanotechnology” at the UAR (Upper Austrian Research). Dr. Sonnleitner ran this division for four years. Dr. Sonnleitner is well published, having authored more than 20 publications in the field.